A publication for alumni, donors, faculty and friends of UC Davis Health

Volume 14 • No 2 • Fall 2017

Noteworthy

They said it!

Julie Schweitzer, Ph.D.

“School work is probably a lot less interesting than playing with the toy. You’re looking at competing activities here. It seems to me that it would be more distractive than helpful.”

Julie Schweitzer, Ph.D., director of the Attention, Impulsivity and Regulation program at the UC Davis MIND Institute, in a HealthDay story on the fidget spinner toy craze.
Paul Knoepfler, Ph.D.

“They were just saying, ‘Screw the rules, we’re just going to set up shop and put up a website and start injecting people with stem cells.’ I saw that as a threat, first to patients, but to the field as well.”

UC Davis stem cell researcher Paul Knoepfler, Ph.D., in a Science magazine profile on his role as a watchdog blogger.
John Olichney, M.D.

“We have a real knowledge gap in accurately knowing if dementia is different in minorities as compared to whites.”

John Olichney, M.D., a neurologist and clinical director of the UC Davis Alzheimer’s Disease Center, in an International Business Times article on dementia research participation rates in African-Americans. The UC Davis center reaches out to African-American and Latino communities to help ensure research is fully representative.
Simon Cherry, Ph.D.

“It will allow (pharmaceutical researchers) not just to ask, ‘Is my drug reaching a tumor?’ but ‘How much is in the liver?’ for example. So it can help us identify the best drug candidates, and we can hopefully have fewer failures in clinical trials.”

UC Davis biomedical engineering professor Simon Cherry, Ph.D., with medical physicist Ramsey Badawi, Ph.D., in a Science article on their work develop the world’s first total-body PET scanner.
Jan Nolta, Ph.D.

“The issue of so-called clinics offering unauthorized therapies that are listed on ClinicalTrials.gov is a big problem. Patients are led to believe that this listing makes the trials legitimate, but in fact it does not.”

Jan Nolta, Ph.D., director of the UC Davis Stem Cell Program and Institute for Regenerative Cures, in a Medscape article about potentially misleading listings on the federal clinical trials website.
UC Davis Health Magazine logo A publication for alumni,
donors, faculty and friends
of UC Davis Health Volume 14 • No 2 • Fall 2017

In this issue